Sources of variability in clinical trials of new drugs for epilepsy.
Leppik
I E
IE
Department of Neurology and Pharmacy, University of Minnesota, Minneapolis.
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence* / Q000379:methods; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004347:Drug Interactions; D004569:Electroencephalography / Q000187:drug effects; D004827:Epilepsy / Q000145:classification / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D013577:Syndrome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D000927:Anticonvulsants